9-BROMO-2-IODO-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPINE, 95.0%, 10g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid, 95.0%, 5g

1-(2,6-Difluorophenyl)ethylamine, 95.0%, 1g

3-methyl-4'-piperidinomethyl benzophenone, 97.0%, 1g

2-tert-Butyloxycarbonylaminomethyl-5-(3,4-dichlorophenyl)-[1,3,4]oxadiazole, 95.0%, 1g

(S)-4-(methoxymethyl)-1,3-dioxolan-2-one, 98%, 1g

3-{1-[(tert-butoxy)carbonyl]piperidin-3-yl}benzoic acid, 97.0%, 250mg

(9H-Fluoren-9-yl)methyl (2-(2-aminoethoxy)ethyl)carbamate hydrochloride, 95.0%, 10g

3-Hydroxypropanehydrazide, 95.0%, 1g

(R)-1-N-Boc-Piperidine-3-ethanol, 97.0%, 5g

9-Methyl-3-methylene-2,3-dihydro-1H-carbazol-4(9H)-one, 97%, 5g

3-Bromomethyl-benzenesulfonamide, 95.0%, 5g

Acide 2-amino-5-bromobenzoïque, min 95 %, pour la biochimie, 25 g, emballage plastique.